Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cv Sciences Inc
(OP:
CVSI
)
0.0527
+0.0007 (+1.35%)
Streaming Delayed Price
Updated: 12:55 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cv Sciences Inc
< Previous
1
2
3
4
5
6
7
Next >
Cannabis Stock Gainers And Losers From July 11, 2023
July 11, 2023
Via
Benzinga
Cannabis Stock Movers For July 10, 2023
July 10, 2023
Via
Benzinga
CV Sciences Inc Q1 Revenue Stagnates YoY, Here Is What You Need To Know
May 15, 2023
CV Sciences, Inc. (OTCQB: CVSI) released its financial results today for the first quarter ended March 31, 2023, revealing revenues of $4.1 million for the first quarter of 2023 compared to $4.4...
Via
Benzinga
CV Sciences FY22 Revenue Declines 19% To $16.2M
March 29, 2023
CV Sciences, Inc. (OTCQB: CVSI) FY 2022 revenue was $16.2 million, a 19% decrease compared to $20.0 million for 2021. Q4 2022 Financial Highlights
Via
Benzinga
Why Is CV Sciences Stock Up Today?
November 14, 2022
CV Sciences (OTCQB: CVSI) shares were trading 10.69% higher at $0.044 per share at the time of writing Monday morning on company's third-quarter financial results.
Via
Benzinga
CV Sciences Adds +PlusCBD Relief Softgels To Wellness Line Of CBD Products
March 08, 2022
CV Sciences, Inc. (OTCQB:CVSI) added +PlusCBD ...
Via
Benzinga
Popular CBD Brand Questions Study: 'Misleading To Consumers And Damaging To The Industry'
April 10, 2023
NextEvo Naturals recently released results from a third-party study on 16 CBD products that were allegedly randomly selected for the research. The brand commissioned Coral Reef Labs to conduct this...
Via
Benzinga
CBD And Nicotine Formula To Treat Smokeless Tobacco Addiction Receives Patent From Japan, FDA Approval Next
March 23, 2023
CV Sciences, Inc. (OTCQB: CVSI) received a formal certificate of grant from the Japan Patent Office for its patent application 7216697.
Via
Benzinga
Biden's Pardon For Cannabis Offenders: 27 Reactions From Politicians, Industry Executives And Advocacy Orgs
October 07, 2022
President Joe Biden announced on Thursday that he will pardon all prior federal offenses for simple marijuana possession, sending
Via
Benzinga
The CBD Gold Rush Is Over (And That's A Great Thing For Consumers)
August 24, 2022
By Bharat Ayyar Disclaimer: I am not a financial advisor. Nothing contained in this post should be construed as investment advice. CV Sciences (OTC: CVSI), the company behind +PlusCBD, had a meteoric...
Via
Benzinga
Marijuana As An Appetite Suppressant? It's A Possibility
June 30, 2022
Using cannabis as an appetite suppressant for weight management may seem counterintuitive, but one rare cannabinoid may have just that effect. Delta-9 (d-9)-dominant tetrahydrocannabivarin (THCV) has...
Via
Benzinga
Nutrition Giant GNC To Distribute CBD Products In 770 Stores In US
January 06, 2022
Hemp cannabidiol (CBD) products maker CV Sciences, Inc. (OTCQB:
Via
Benzinga
CV Sciences Q1 Revenue Down 8.33%, CEO Encouraged As PlusCBD Brand Gains Market Share
May 16, 2022
CV Sciences, Inc. (OTCQB: CVSI) released its financial results for the quarter ended March 31, 2022, revealing a revenue drop of 8.33% to $4.4 million YoY. First Quarter 2022 and Recent Financial and...
Via
Benzinga
A Preview Of CV Sciences's Earnings
March 30, 2022
CV Sciences (OTC:CVSI) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that CV Sciences will...
Via
Benzinga
Dry January Got You Down? Cannabis To The Rescue With Tokes, Yummy Gummies And More
January 11, 2022
After the hustle and bustle of the holidays, many people are looking to curtail their consumption of alcohol and are therefore partaking in
Via
Benzinga
CV Sciences Launches +PlusCBD Pain Relief Topicals With Products For Athletes, Arthritis Patients
January 11, 2022
CV Sciences, Inc. (OTCQB:CVSI) is launching +PlusCB...
Via
Benzinga
Is Medical Marijuana Really A Slippery Slope? CVSI Distribution Agreement with GNC
January 05, 2022
The Best Daily Overview Of The Cannabis Space CV Sciences Announces New Distribution Agreement with GNC. $CVSI ...
Via
Benzinga
Trending Up: $TLLTF $VRNOF $UNRV, GOP Cannabis Bill, Cause for Hope? — Cannabis Daily November 16, 2021
November 16, 2021
The Best Daily Overview Of The Cannabis Space Representativ...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Week In Cannabis: Stocks Down, Republican Legalization Bill, Germany, Uruguay, Earnings, New ETF And More
November 19, 2021
Below is a recap of the main news related to the cannabis industry and markets for the week of November 15, 2021.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
CV Sciences 3Q Financials Continue To Improve Cost Structure, Praises California CBD Legislation
November 15, 2021
CV Sciences, Inc. (OTCQB:CVSI), a supplier and manufacturer...
Via
Benzinga
Topics
Supply Chain
Exposures
Supply Chain
Earnings Preview For CV Sciences
November 12, 2021
CV Sciences (OTC:CVSI) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
Pharmaceutical & Hemp Wellness Segments Of Cannabidiol Market Could See the Fastest Growth Rates Through 2028
November 15, 2021
Palm Beach, FL – November 15, 2021 – FinancialNewsMedia.com News Commentary – Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects....
Via
FinancialNewsMedia
EXCLUSIVE: CV Sciences Launches New Product Line Featuring Full Range Of Phytocannabinoids
October 15, 2021
CV Sciences Inc (OTC:CVSI) is launching a ne...
Via
Benzinga
Looking Into CV Sciences's Return On Capital Employed
October 01, 2021
CV Sciences (OTC:CVSI) brought in sales totaling $5.13 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 12.75%, resulting in a loss of $3....
Via
Benzinga
Ryder Cup To Retirees: Many Golfers Say CBD Is A Hole In One For Their Game
September 17, 2021
Professional golf is one of, if not the most cannabis-friendly globally played sports today. While Olympians and athletes in other sports cont...
Via
Benzinga
Cantor Remains Neutral on Charlotte's Web, cbdMD and CV Science CBD Stocks, Sector Could Benefit From Federal Legalization
August 13, 2021
Cantor Fitzgerald released a new report analyzing the possible effects of CBD reform in the stock performance of Charlotte...
Via
Benzinga
American Cannabis Operator Index Lost 0.6% This Year, Best Players In July: Columbia Care, Lowell Farms, Ayr Wellness & Ascend Wellness
August 02, 2021
The American Cannabis Operator Index declined for the fifth straight month falling 10.7% to 62.66. The index, which launched in Oc...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Slight Correction For Cannabis Stocks After A Ramping Week, Check Out The Top Movers For July 30, 2021
July 30, 2021
GAINERS: Rhinomed (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Week In Cannabis: Amazon Lobbies In DC, Colombia's New Law, Big IPOs And More
July 23, 2021
Below is a recap of the main news related to the cannabis industry and markets for the week of July 16, 2021.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Watch Planet 13's CEO & Matt Hawkins From Entourage Effect Capital At Benzinga Cannabis Hour 7/21
July 23, 2021
Benzinga’s Cannabis Hour is a live show for cannabis investors. On Thursday's show, hosts Elliot L...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.